INTRODUCTION
The mammalian inflammatory response has evolved to control infection by microbial pathogens before the onset of sepsis and death, while also playing important roles in tissue repair (Medzhitov, 2008) . Despite its utility, when the inflammatory response is activated inappropriately, it may be directed against specific self-tissue antigens and cause serious disease. The outcome can be debilitating to important organ systems and is the underlying cause of widespread human autoimmune disorders.
Recent work has revealed that IL-17-producing inflammatory CD4 + T cells, or T helper 17 (Th17) cells, are critical mediators of chronic, autoimmune inflammation (Bettelli et al., 2006; Ivanov et al., 2006) . Th17 cell development is driven by cytokines produced primarily by cells of the innate immune system, including transforming growth factor-b (TGF-b), interleukin-6 (IL-6), IL-23, and IL-1 (Bettelli et al., 2006; Langrish et al., 2005; Veldhoen et al., 2006) . The impact of Th17 cells was first made evident in mice, where overexpression of IL-17 led to increased granulopoiesis in vivo (Schwarzenberger et al., 1998) . Subsequent studies demonstrated that inhibition of IL-17 in mice can ameliorate several autoimmune disorders including experimental autoimmune encephalomyelitis (EAE), collagen-induced arthritis (CIA), and inflammatory bowel disease (IBD) (Ivanov et al., 2006; Komiyama et al., 2006; Murphy et al., 2003) .
Micro-RNAs (miRNAs) are a class of noncoding RNAs that modulate gene expression at the posttranscriptional level and are involved in regulating several aspects of inflammation (O'Connell et al., 2010; Xiao and Rajewsky, 2009) . Specific miRNAs, such as miR-146a, miR-155, and miR-132, were initially shown to be upregulated during the macrophage inflammatory response (O'Connell et al., 2007; Taganov et al., 2006) . The functional impact of certain miRNAs on inflammation has been demonstrated in vivo. Mice deficient in miR-223, a miRNA that is enriched in myeloid cells, display elevated granulocyte numbers and increased immunity against fungi (Johnnidis et al., 2008) . Other studies have found important roles for miRNAs in lymphocytes. For instance, enforced expression of the miR-17-92 cluster in T cells or specific deletion of Dicer in T regulatory (Treg) cells both trigger lethal autoimmune conditions (Chong et al., 2008; Liston et al., 2008; Xiao et al., 2008; Zhou et al., 2008) . miR-155 was among the first miRNAs linked to inflammation by virtue of its potent upregulation in multiple immune cell lineages by Toll-like receptor (TLR) ligands, inflammatory cytokines, and specific antigens (Haasch et al., 2002; O'Connell et al., 2007; Taganov et al., 2006; Thai et al., 2007) . A wide variety of immunologically relevant targets of miR-155 have been reported, implying distinct roles in mammalian immunity. Among these roles, miR-155 has been shown to be important for immunoglobulin (Ig) class switching to IgG in B cells via targeted repression of activation-induced cytidine deaminase (AID) and the transcription factor PU.1 (Dorsett et al., 2008; Rodriguez et al., 2007; Thai et al., 2007; Vigorito et al., 2007) . The fitness of T regulatory cells is influenced by direct repression of suppressor of cytokine signaling 1 (SOCS1) by miR-155 (Lu et al., 2009) . In myeloid cells, overexpression of miR-155 drives a myeloproliferative disorder through a mechanism involving reduced src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) expression, suggesting that miR-155 is acting as a positive regulator of inflammation (O'Connell et al., 2008 (O'Connell et al., , 2009 . Despite these reported functions of miR-155 in both innate and adaptive immune cells, to date there has been little genetic evidence that endogenously expressed miR-155 actually impacts inflammatory responses in vivo. In the present study, we investigated the role that miR-155 might play during antigen-specific inflammatory responses against self-tissues.
RESULTS

Mir155
-/-Mice Are Resistant to EAE Induced by Myelin Oligodendrocyte Glycoprotein To identify a possible role for miR-155 in mediating tissuespecific autoimmune inflammation, a mouse model of EAE was used. Both wild-type (WT) and Mir155 À/À mice were immunized with 100 mg of the myelin oligodendrocyte glycoprotein (MOG) peptide emulsified in complete Freund's adjuvant (CFA) followed by administration of pertussis toxin. As anticipated, WT mice first displayed neurologic symptoms approximately 9 days postimmunization, with peak disease severity on day 14 (average clinical score of 2.1) and 100% disease incidence ( Figures 1A and 1B) . In contrast, Mir155 À/À mice exhibited a later onset of symptoms on day 11, with a low peak disease severity on day 15 (average clinical score of 0.3). Unlike the WT controls, the disease incidence in Mir155 À/À mice was only 60% ( Figures   1A and 1B) . On day 25, mice were sacrificed and underwent further evaluation including tissue histological analysis. Hematoxylin and eosin (H&E) brain cross-sections were scored for disease severity ( Figures 1C and 1D ). As expected, WT mice suffered from heavy perivascular congestion, parenchymal infiltration, and focal meningeal lymphocytosis. However, brain tissue from Mir155 À/À mice showed minimal histologic evidence of inflammation consistent with the mild clinical manifestation of EAE ( Figures 1C and 1D ). Furthermore, upon analyzing the draining lymph nodes (LNs) and spleens from both groups of mice, we found decreased overall cellularity in LNs from Mir155 À/À mice and compositionally fewer CD11b + myeloid cells in Mir155 À/À spleens ( Figures 1E and 1F ). Both of these observations are consistent with a reduced inflammatory condition in Mir155 À/À mice.
Lethally irradiated WT C57BL/6 mice were next reconstituted with either Mir155 +/+ or Mir155 À/À bone marrow (BM) cells. After 4 months, proper engraftment and localization of the miR-155 deficiency to the hematopoietic compartment was confirmed by assaying miR-155 amounts in activated splenic B cells ( Figure 1G ). After induction of EAE, mice with Mir155 +/+ hematopoietic cells exhibited a faster and more severe disease phenotype than mice containing Mir155 À/À hematopoietic cells ( Figure 1H ). In a separate experiment, 25 3 10 6 WT encephalitogenic splenocytes from day 12 EAE WT mice were transferred into WT or Mir155 À/À hosts, which were monitored for the presence of clinical symptoms. Both groups began to show symptoms by day 8 postadoptive transfer and had comparable disease scores throughout the 22 day time course ( Figure 1I ). Furthermore, both cohorts had a disease incidence of 100% ( Figure S1 available online). Taken together, these data demonstrate that miR-155 functions in the hematopoietic compartment to promote EAE.
-/-Mice Exhibit Defective Inflammatory T Cell Development during EAE Th17 and Th1 cells are hematopoietic cells that develop during tissue-specific inflammatory responses and play a pivotal role in enhancing inflammation (Littman and Rudensky, 2010 Figure 2C ). In parallel, 3 [H] thymidine incorporation assays via total splenocytes produced similar differences ( Figure 2D ). Tissue culture supernatants from these experiments were assayed for IL-17A and IFN-g production by ELISA in response to MOG 35-55 stimulation. MOG 35-55 -stimulated Mir155 À/À splenocytes showed minimal production of both of these cytokines compared to WT splenocytes, further demonstrating a defective CD4 + T cell-driven recall response to antigen ( Figure 2E ). We next investigated whether a defect in inflammatory T cell development could also be detected during the initial onset, or induction phase, of EAE. Mice were harvested on day 13 postimmunization with MOG 35-55 and the LNs from Mir155 À/À mice had reduced numbers of live cells compared to WT controls, whereas the brains (CNS) and spleens from the two groups had similar total cell numbers ( Figure S3 ). Inflammatory T cell development in the brains, LNs, and spleens was next assessed. splenocytes, and deficiencies in both IL-17A and IL-23 p19 mRNAs were also observed ( Figure 3C ). Intracellular staining revealed diminished numbers of Th17 and Th1 CD4 + T cells in Mir155 À/À spleens ( Figure 3D ). The recall response to MOG was also tested with splenocytes from day 13 EAE mice. Immunity miRNA-155 Promotes Autoimmune Inflammation seems unlikely to be related to the Treg cell population in these animals. Also in agreement with earlier studies Thai et al., 2007; Vigorito et al., 2007) with KLH and in the contralateral footpad with saline. After 48 hr, footpad thickness was measured to assess the delayed type hypersensitivity (DTH) response. As expected, WT mice had a substantial increase in footpad inflammation after KLH administration compared to saline alone ( Figure 4A ). In contrast, Mir155 À/À mice exhibited reduced amounts of swelling in response to KLH as compared to WT mice ( Figure 4A ). Splenocytes and LNs were also harvested on day 10, and Mir155
LNs had significantly fewer total cells than WT controls, consistent with a blunted inflammatory response ( Figure 4B ). Cells from both organs were restimulated with KLH for 3 days. Although LN cell and splenocyte proliferative differences were not observed in response to stimulation with KLH ( Figure 4C ), substantial reductions in IL-17A, IFN-g, and IL-6 production were seen in Mir155 À/À versus WT splenocytes and LN cells during recall responses ( Figure 4D ). These data support a general role for miR-155 in mediating antigen-and tissuespecific inflammation and point to a consistent defect in inflammatory T cell production. IL-17A production by splenocytes (pg/ml) IFN-γ production by splenocytes (pg/ml) IL-6 production by splenocytes (pg/ml) 5A and 5B). As in previous reports (Haasch et al., 2002) , we also observed upregulation of miR-155 in activated CD4 + T cells ( Figure 5C ), and we detected expression of BIC and miR-155 in CD4 + T cells grown in conditions that promote Th17 cell development ( Figure 5D ). Reduced expression of IL-17A mRNA was measured in Mir155 À/À compared to WT CD4 + T cells under Th17 cell skewing conditions ( Figure 5D ). These results reveal a T cell-intrinsic role for miR-155 in promoting the in vitro development of Th17 cells.
To test whether miR-155 plays a T cell-intrinsic role in driving inflammatory T cell development during EAE in mice, we adoptively transferred 6 3 10 6 purified naive Mir155 +/+ or Mir155 Figure 6D ). The brain was harvested on day 23 postimmunization, and the development of Th17 and Th1 cells was determined by intracellular staining for IL17A and IFN-g, respectively (Figures 6E and 6F; Figure S4 ). Although both mouse groups had roughly equivalent percentages of both Th17 and Th1 cells among the total CD4 + T cells in the brain, these cellular subsets were comprised predominately of the adoptively transferred CD45. . See also Figure S4 .
Immunity miRNA-155 Promotes Autoimmune Inflammation Th17 cells to develop, they must receive signals from relevant inflammatory cytokines, such as IL-6 and IL-23, which are produced by GM-CSF-derived DCs (Gutcher and Becher, 2007) . Therefore, we examined the impact of miR-155 on the gene expression profile of LPS-activated DCs, which express high levels of miR-155 ( Figures 7A and 7B) . Total RNA was collected from purified WT or Mir155 À/À DCs after 20 hr of LPS treatment and subjected to a microarray analysis. Several targets of miR-155 were expressed at higher amounts in Mir155 À/À versus WT control DCs ( Figure 7C ). Among these, SHIP1 and SOCS1 have been shown to be directly targeted by miR-155 (Androulidaki et al., 2009; Lu et al., 2009; O'Connell et al., 2009) and to function by negatively regulating cytokine production by DCs Shen et al., 2004) . Their elevated expression in Mir155 À/À DCs was confirmed via quantitative PCR (qPCR) and by immunoblotting ( Figure 7D ). Consistent with the elevated expression of these negative regulators, decreased expression of several inflammatory cytokine genes including IL-6, IL-23 p19, and IL-12 and IL-23 p40 was observed in Mir155 À/À DCs ( Figure 7C ). These results were confirmed by qPCR and ELISA, which also detected a subtle decrease in tumor necrosis factor-a (TNF-a) production (Figures 7E and 7F) . To further corroborate these findings, miR-155 was overexpressed in GM-CSF-derived DCs via a retroviral vector described previously (O'Connell et al., 2009) , and higher amounts of IL-6, IL-23 p19, IL-12 and IL-23 p40, and TNF-a mRNA expression were observed after LPS treatment ( Figure 7G ). We also tested whether Mir155 À/À DCs were defective in their ability to induce CD4 + T cell proliferation after presentation of cognate antigens. Both Mir155 +/+ and Mir155 À/À DCs induced equivalent proliferation of 2D2 or OT2 CD4 + T cells that recognize MOG or an ovalbumin peptide, respectively ( Figure 7H ). Taken together, these experiments demonstrate that miR-155 promotes DC expression of specific cytokines required for inflammatory T cell development.
DISCUSSION
We have shown here that miR-155 plays an important role in driving chronic inflammation that is inappropriately directed at tissue-specific antigens, a destructive process that is at the heart of human autoimmune diseases. At the cellular level, Mir155 À/À mice exhibit defective inflammatory T cell development during the induction phase of autoimmunity. This appears to be largely due to miR-155 function in CD4 + T cells, and may also involve insufficient production of inflammatory cytokines by DCs. Although diminished inflammatory T cell development is beneficial in the context of autoimmunity, it is detrimental to mammals after infection by certain pathogens. Thus, our observations also suggest a protective role for miR-155 in response to infection. miR-155 expression is dramatically increased in CD4 + T cells upon their activation, suggesting functional importance for this miRNA in activated T cells (Haasch et al., 2002) . Our results expand upon previous work, which demonstrated that miR-155 can impact Th1 cell and Th2 cell lineage skewing in vitro Thai et al., 2007) , by finding a role for miR-155 in Th17 cell biology both in vitro and in vivo. Recently, inhibition of miR-326 via a miRNA ''sponge'' was shown to reduce EAE symptoms by preventing Th17 cell differentiation also through a T cell-intrinsic mechanism (Du et al., 2009 ). Thus, multiple miRNAs appear to directly regulate inflammatory T cell development, as suggested by early studies analyzing Dicer-deficient T cells (Muljo et al., 2005) . Many direct targets of miR-155 in CD4 + T cells have been identified, some of which impact Th cell lineage decisions . For instance, c-Maf is targeted by miR-155 and functions as a promoter of Th2 cell development , while SOCS1 is repressed by miR-155 in both FoxP3 + CD4 + Treg cells and FoxP3 À CD4 + T cells and impacts Treg cell fitness (Lu et al., 2009) . In general, a complex picture of how miR-155 directs T cell developmental pathways is emerging and it appears to involve many targets and pathways. This may also be true for miR-155's positive role in Th17 cell development. On one hand, miR-155 might function to block the inhibitory impact of cytokines such as IL-4 and IFN-g on the Th17 cell differentiation pathway. miR-155 has been shown to limit production of IL-4 by CD4 + T cells through repression of c-Maf , while IFN-gR mRNA is directly targeted by miR-155 in CD4 + T cells (Banerjee et al., 2010) . However, we found that WT CD4 + T cells restore EAE disease severity following their adoptive transfer into Mir155 À/À mice. This argues against a major role for elevated production of a secreted inhibitory molecule like IL-4 being responsible for the reduced EAE observed in Mir155 À/À mice because it would also inhibit the transferred WT T cells through a paracrine mechanism. Alternatively, it is possible that miR-155 can positively regulate signaling pathways that promote Th17 cell formation. This could be achieved via repression of proteins that function to negatively regulate signaling pathways that are activated by TGF-b, IL-6, and IL-23. Although it is unclear whether miR-155 directly regulates these pathways in CD4 + T cells, recent studies found that miR-155 targets Sma-and Mad-related protein 5 (Smad5) in B cell lymphoma cells (Rai et al., 2010) and activates signal transducer and activator of transcription 3 (Stat3) in breast cancer cells (Jiang et al., 2010) , factors involved in TGF-b and IL-6 signaling, respectively. Moving forward, the identity and relative importance of each target of miR-155 during the development of different T cell lineages, including Th17 cells, should continue to be investigated, and may reveal a differential importance for unique targets of miR-155 depending on the T cell subset. Interestingly, a previous study found that Mir155 work demonstrates that miR-155 is upregulated in GM-CSFderived DCs and functions to enhance production of these cytokines. This may contribute to the defects in Th17 cell development and tissue-specific inflammation observed in the Mir155 À/À mice.
Additionally, because Th17 cells are a primary source of GM-CSF during EAE (Ponomarev et al., 2007) , they are thought to reinforce this chronic inflammatory condition by generating additional DCs. Thus, the defective production of Th17 cells in Mir155 À/À mice during EAE may also explain the reduced amounts of GM-CSF observed during our splenocyte recall response experiments. Together, our data suggest a role for miR-155 in regulating both the production and function of GM-CSF-derived DCs in the promotion of autoimmune inflammation. Elevated expression of miR-155 has been observed in brain lesions from multiple sclerosis (MS) patients (Junker et al., 2009 ) and in synovial samples from patients with rheumatoid arthritis (RA) (Stanczyk et al., 2008) . Human trials have found that inhibition of the IL-23-IL-17 inflammatory axis via blocking antibodies can reduce the severity of psoriasis and rheumatoid arthritis (Steinman, 2010) . Based upon this expression profile and our current study, miR-155 may be an effective therapeutic target in the treatment of a range of autoimmune conditions where Th17 cells have been shown to drive disease. However, delivery of miRNA inhibitors to specific cell types in vivo remains a difficult challenge.
In addition to inflammatory T cells, many autoimmune conditions, including human MS, RA, and systemic lupus erythematosus (SLE), also involve the actions of auto-antibodies that have been shown to exacerbate these diseases. Beyond its role in mediating inflammatory T cell development as identified in our current study, previous reports have clearly shown that miR-155 is important for production of antigen-specific IgGs Thai et al., 2007; Vigorito et al., 2007) . Therefore, modulation of miR-155 may be able to treat conditions that depend both upon humoral and cell-mediated immune mechanisms, making it a versatile therapeutic target.
EXPERIMENTAL PROCEDURES Mice
All experiments were approved by the Caltech Institutional Animal Care and Use Committee (IACUC). Mir155
+ , OT2, and 2D2 mice are all on a C57BL/6 genetic background. For bone marrow reconstitutions, mice were conditioned with 1000 Rads via a Cs137 source prior to injection of donor BM.
Mouse Models of EAE and DTH For induction of EAE, mice were injected subcutaneously (s.c.) into the base of the tail with a volume of 200 ml containing 100 mg/ml MOG 35-55 peptide (GenScript) emulsified in complete Freund's adjuvant (CFA). Mice were also injected intraperitoneally (i.p). with 200 ng of pertussis toxin on days 0 and 2, and clinical symptoms were scored regularly according to the following criteria: 0, no symptoms; 0.5, partially limp tail; 1, completely limp tail; 1.5, impaired righting reflex; 2, hind limb paresis; 2.5, hind-limb paralysis; 3, forelimb weakness; 4, complete paralysis; 5, death. For induction of DTH responses, keyhole limpet hemocyanin (KLH) was purchased from Calbiochem. Mice were immunized s.c. at the base of the tail with 100 mg KLH in 200 ml CFA. To assess DTH, all mice involved in the studies were given 50 mg KLH in 50 ml PBS intradermally into the left foot pad and 50 ml phosphate buffered saline (PBS) alone in the right foot pad 8 days after the immunization. 2 days later, foot pad swelling was measured.
Cell Culture and Reagents DCs were derived from WT or Mir155 À/À RBC-depleted bone marrow via rGM-CSF (ebioscience) at a concentration of 20 ng/ml in complete RPMI (supplemented with 10% FBS, 100 units/ml penicillin, 100 units/ml streptomycin, 50 mM beta-mercaptoethanol). Cells were cultured at 5% CO 2 and 37 C in a humidified incubator. DCs were stimulated with E. coli LPS (Sigma) at a concentration of 100 ng/ml. For Th17 cell skewing, CD4 + splenocytes were cultured in complete RPMI, plate-bound CD3 antibodies, and soluble CD28 antibodies (2 mg/ml), IL-6 (50 ng/ml), and TGF-b (2 ng/ml) ( 
Intracellular Staining and Flow Cytometry
To detect intracellular expression of IL-17A, IFN-g, or FoxP3 in CD4 + splenocytes, LNs or brain cells (purified with Percoll) were first treated with 750 ng/ml ionomycin and 50 ng/ml phorbol myristate acetate (PMA) (Calbiochem) in the presence of 0.5 ml of GolgiPlug (BD Biosciences) for 4-5 hr at 37 C. Cells were subsequently surface stained with CD4 + antibodies and then permeabilized and fixed in 100 ml of eBioscience Perm-Fix solution overnight at 4 C. Cells were washed once in perm wash buffer (eBioscience) and then stained with 0.3 mg of fluorophore-conjugated anti-IL-17A, or FoxP3 (eBioscience) for 20 min at 4 C. Fluorophore-conjugated monoclonal antibodies specific to CD11b (Mac1), CD33, or B220 (eBioscience) were used to stain red blood cell (RBC)-lysed splenocytes or LN cells. Antibodies recognizing CD11c (eBioscience) were also used to stain in vitro derived DCs. After washing, stained cells were assayed with a BD FACSCalibur flow cytometer and results further processed with FlowJo software.
Microarray and qPCR
Total RNA was isolated from magnetic-activated cell separation (MACS)-sorted, LPS-activated CD11c + myeloid DCs derived from WT or Mir155 À/À BM via Trizol (Invitrogen) per manufacturer's instructions. Global mRNA expression amounts were next assayed with the Affymetrix total mouse genome array V 2.0 as described previously (O'Connell et al., 2008) , and the data were analyzed further with Rosetta Resolver software. Sybrgreen-based quantitative real-time PCR (qPCR) was conducted with the 7300 Realtime PCR system (Applied Biosystems, Foster City, CA) to assay BIC, SHIP1, SOCS1, IL-17A, IL-6, IL-23 p19, IL-12 and IL-23 p40, TNF-a, and L32 mRNA amounts with gene-specific primers (sequences available upon request). Mature miR-155 and sno202 RNA amounts were assayed with specific Taqman probes from Applied Biosystems. For all experiments, mRNA was normalized to L32 and miRNA to sno202.
ELISAs
To detect protein expression of GM-CSF, IL-6, IL-17A, IFN-g, IL-23 p19 and p40, IL-12 and IL-23 p40, and TNF-a, ELISAs were performed with cytokinespecific kits from eBioscience and carried out according to the manufacturer's instructions. Serum IgG antibodies against MOG 35-55 were assayed by plating serial dilutions of mouse serum on plates coated with MOG 35-55 and bound antibodies detected with biotinylated anti-mouse IgG antibodies and Streptavidin horseradish peroxidase (HRP) (Southern Biotech).
Immunoblotting Cellular extract was size fractionated via sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting was performed in accordance with standard protocols. Specific antibodies were used to detect SHIP1, SOCS1, and b-actin.
Retrovirus Production and Infections
Murine stem cell virus (MSCV)-based retroviruses expressing murine miR-155 were prepared as described previously (O'Connell et al., 2009 ) and used to spin infect freshly isolated WT bone marrow. Immediately following, cells were cultured in GM-CSF containing medium until day 7 before LPS stimulation.
Histological Examination of Central Nervous System Tissues
Brains and spinal cords from EAE mice were dissected and fixed in formaldehyde for 48 hr. Tissue sections were next prepared, stained with H&E, and visualized with a Nikon Eclipse 50i microscope, and photographed with a Spot digital camera. Sections were scored by a pathologist blinded to the genotype of the tissue or the clinical severity of disease according to the following criteria: 0, no sign of infiltrate; 1, perivascular congestion (light); 2, perivascular congestion (heavy); 3, perivascular congestion (heavy) and parenchymal infiltrate; 4, focal meningeal lymphocytosis; 5, extensive sclerosis.
Statistical Analysis
Statistical significance was determined by performing a two-tailed t test. p values < 0.05 were considered significant.
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